Bank of America’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
Other funds holding IGC
VCM
VFT
LC
Bank of America's IGC Position: Q1 2026 in Review
Bank of America sold out of IGC Pharma (IGC) in Q1 2026, closing a stake of 1,808 shares — an estimated $508 sold.
Bank of America first reported a position in IGC in Q2 2015 and held it in 18 quarters. The position peaked at $144K in Q3 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.
- Bank of America reported no remaining IGC Pharma position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 1,808 IGC Pharma shares in Q1 2026, an estimated $508.
- Bank of America first reported a position in IGC Pharma in Q2 2015 and held it in 18 quarters.
- Bank of America's IGC Pharma position peaked at $144K in Q3 2021.
- 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.